• CCRM

  • Stephanie Leclair

Stephanie Leclair

Corporate Legal Counsel at CCRM

Stephanie LeClair, J.D., B.A. serves as Senior Legal Counsel at CCRM, specializing in corporate commercial and employment legal matters since April 2022. Prior experience includes roles as Senior Commercial Contracts Specialist at GE Healthcare, where expertise in drafting and negotiating commercial contracts was developed, and Associate Lawyer at the Law Office of Matthew Dobbie, handling litigation and corporate matters. Stephanie's diverse legal career also includes winning Amazing Race Canada Season 4, and previous positions as Associate Lawyer with Lawson LLP, Commercial Contract Specialist at GE Healthcare, and Associate Attorney at Krall Law Offices, where a wide range of legal issues including litigation and corporate matters were addressed. Educational credentials consist of a Doctor of Law from the University of Detroit Mercy School of Law and a Bachelor of Arts in Finance from Wayne State University.

Location

Toronto, Canada

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


CCRM

1 followers

Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.


Headquarters

Toronto, Canada

Employees

201-500

Links